Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Altium SA places order to a value of EUR 460 K and PHI communicates sales outlook

Phase Holographic Imaging PHI AB ("PHI" or the "Company") today announces that the Company’s global distributor Altium SA (“Altium”) has placed an order of HoloMonitor® systems and add-ons to a total value of approximately EUR 460 K. The total expected order value from Altium for the full fiscal year of 2024/2025 is estimated to amount to approximately EUR 2 million.Order from Altium The order placed by Altium, amounting to a total value of approximately EUR 460 K, is expected to be shipped in December 2024, meaning that this is assessed to be recognized in the Company’s Q3-report for

Sigrid Therapeutics Secures US Patent for Groundbreaking SiPore[®] Technology in Blood Sugar Management

Stockholm, Sweden, December 2, 2024. The Swedish healthtech company Sigrid Therapeutics today announced that it has been granted a US patent for its SiPore[®] platform technology. As an effective method of lowering blood glucose, SiPore[®] promises to become a breakthrough treatment to reduce the risk of developing metabolic syndrome, type 2 diabetes, insulin resistance, or hyperglycaemia.The United States Patent Office (USPTO) has granted the company patent US 12,121,612 titled “Porous silica material for use as a pharmaceutical or dietary active ingredient”. The patent supports use of

Change in UPM’s Group Executive Team: Susanna Rinne assumes interim role leading UPM Plywood business area as of 1 January 2025

UPM-Kymmene Corporation Stock Exchange Release (Changes board/management/auditors) 2 December 2024 at 09:30 EET Change in UPM’s Group Executive Team Susanna Rinne assumes interim role leading UPM Plywood business area as of 1 January 2025 Susanna Rinne has been appointed as interim Executive Vice President of UPM Plywood business area, effective 1 January 2025. As announced earlier, the current Executive Vice President of UPM Plywood, Mika Kekki, has been appointed to lead the UPM Specialty Papers business area starting from the same date. Susanna Rinne (born in 1970) is

SEB maintain valuation range midpoint at DKK 54 per share

Copenhagen, Denmark, 2 December 2024 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces that SEB reiterates a fair value for Curasight's shares of DKK 54 per share, which implies an upside of 370% from the TO2 warrant strike price of DKK 11.50Following the announcement of Curasight's selection of brain cancer (glioblastoma) as the first indication for uTREAT® with enrolment of the first patient in Q2 2025 and the publication of an additional uTREAT® patent application securing protection until 2043, as well as the publication of the Q3 report, SEB has published

ASSA ABLOY acquires Premier Steel Doors and Frames in the US

ASSA ABLOY has acquired Premier Steel Doors and Frames (“Premier”), a US manufacturer of hollow metal doors and frames, metal building door systems, and aluminium windows. "I am very pleased to welcome Premier into the ASSA ABLOY Group. This acquisition delivers on our strategy to strengthen our position in mature markets through adding complementary products and solutions to our core business,” says Nico Delvaux, President and CEO of ASSA ABLOY. "Premier is a well-known and respected steel door and frame manufacturer, and I’m excited for them to join our division,” says Lucas Boselli,

Change of Auditor

2 December 2024   GiG Software Plc (“GiG” or the “Company”)   Change of Auditor   GiG Software Plc (First North: GiG SDB), a leading B2B iGaming technology company, is pleased to announce the appointment of Forvis Mazars LLP as its new statutory auditor for the financial year ending 31 December 2024.   Following the recent restructuring of the Company and subsequent listing on the Nasdaq First North Premier Growth Market, a change of statutory auditor was required as part of this process.   GiG would like to thank its previous statutory auditor,

Bluestep Bank AB Becomes Enity Bank Group AB

Bluestep Bank AB (publ) has officially changed its name to Enity Bank Group AB (publ), effective December 2, 2024. The group’s consumer-facing brands will continue operating under their current names.The name change, approved by the Swedish Financial Supervisory Authority (Finansinspektionen), has been registered with the Swedish Companies Registration Office. Under the new group name, Enity Bank Group, the company’s established consumer brands – Bluestep Bank, Bank2, and 60plusbanken – remain unchanged and will continue serving customers across Sweden, Norway, and Finland without any

STENOCARE – Innovative New ASTRUM Product Officially Approved for Sale in Norway

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO STENOCARE A/S (“Stenocare” or the "Company") is proud to announce the approval of its innovative product, Astrum 10-10, for sale in Norway. This milestone paves the way for more patients to access the benefits of medical cannabis treatment. Astrum 10-10 is expected to become available to patients within the next 30 days.Since 2019, Stenocare has been collaborating with partners to develop and test next-generation medical cannabis oil products, positioning itself as a frontrunner in prescription-based medical

Africa Oil Announces Results of Share Buyback Program and Provides Share Capital and Voting Rights Update

VANCOUVER, BC, Dec. 2, 2024 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased to announce that the Company repurchased a total of 636,300 Africa Oil common shares during the period of November 25, 2024 to November 29, 2024 under the previously announced share buyback program. The launch of Africa Oil’s normal course issuer bid (share buyback) program, announced by the Company on December 4, 2023, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) No 2016/

Telia Company completes change program and implements decentralized country-led approach

Telia Company has completed its change program announced on September 4  and lowered the company’s cost base through a reduction of 3,000 positions, while decentralizing its organization as part of a new country-led operating model. This will support commercial excellence and in turn deliver profitable growth. As previously communicated, the changes will provide annual savings of at least SEK 2.6 billion and reinforce Telia’s

SSC and Ovzon further broadens and deepens collaboration

Swedish Space Corporation (SSC) and Ovzon have signed a teaming agreement to broaden, deepen and strengthen the already successfully developed partnership with the aim to develop unique sovereign space and satellite capabilities. Sovereign space capabilities allow a country to operate space systems independently, when and where they want. They are important for national security, economic competitiveness and resilience in today’s rapidly evolving geopolitical landscape. Ovzon, with its disruptive Ovzon 3 satellite, and SSC, with its extensive space service portfolio, are uniquely

Eevia is subject to a possible reverse takeover

Eevia Health Plc (”Eevia" or "The Company") received a proposal for a reverse takeover (RTO) from Stemtech Corporation[1] (“Stemtech”), a US company, on November 10. The proposal suggests that Eevia buy the US company's assets (“Stemtech Assets”) and issue new shares to the US company, providing that Stemtech will own c. 85% of the new outstanding shares after such a transaction. Stemtech recently announced its pending merger with Seacret Direct LLC, DBA VIÁGO ("Viago"), and the Stemtech Assets include the assets of Viago and Stemtech. Stemtech's valuation would be approximately 40 MUSD,

Terveystalo updates its medium-term financial targets

Terveystalo Oyj, Stock Exchange Release, 2 December 2024 at 08:00 (EET) Terveystalo’s Board of Directors has approved the company’s updated financial targets and dividend policy for the medium term. All targets have been updated to reflect the company's improved performance and focus on value creation. Terveystalo’s updated financial targets and dividend policy are as follows: Profitable growth: · EPS to grow on average by 10% p.a. · We expect faster earnings per share growth in 2025, as fewer items affecting comparability are expected Moderate leverage ratio: · Net

Divestment of private and life insurance operations in Finland finalised

On 31 May 2023 Handelsbanken entered into an agreement to divest the private and life insurance operations in Finland. The divestments have now been completed and the operations have been transferred to S-bank Abp and Fenni Life Insurance, respectively. The transactions included lending volumes of approximately EUR 2.5 billion (SEK 28 billion), corresponding to a risk weighted exposure amount of approximately EUR 1.0 billion (SEK 11 billion), as well as deposit volumes of approximately EUR 0.9 billion (SEK 10 billion) and total assets under management of approximately EUR 2.0 billion (

The last day of trading in warrants of series TO2 is on the 3[rd] of December 2024

The 3[rd] of December 2024 is the last day of trading in warrants of series TO2, which were issued in connection with Curasight A/S ("Curasight" or the "Company") preferential rights issue and directed issue of units in September 2024. The exercise period runs until the 5[th] of December 2024.In connection with the Company's preferential rights issue and directed issue of units, carried out in September 2024, 3,683,814 warrants of series TO2 were issued. Holders of TO2 have the right to subscribe for one (1) new share in Curasight at a price of DKK 11.50 per share during the exercise period,

Business Sweden leads a large business delegation to South Korea and Japan from 3–6 December alongside Prime Minister Ulf Kristersson.

As part of the Government’s Asia initiative, Business Sweden is leading a large business delegation to South Korea and Japan to strengthen and expand trade relations with these key partners.“We are taking important steps to further deepen trade relations with Japan and South Korea. A significant business delegation will accompany the Prime Minister and ministers on this visit. Asia continues to grow in importance, with high growth expected to persist. Countries like South Korea and Japan are vital partners with whom we aim to foster closer cooperation,” says Jan Larsson, CEO of Business

Zwipe AS – Commencement of Exercise Period for Warrants issued in the 2023 Rights Issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN ZWIPE AS. SEE ALSO THE SECTION "IMPORTANT INFORMATION" BELOW IN THIS DOCUMENT.Reference is made to the stock exchange announcements published by Zwipe AS (the "Company") on 14 December 2023, regarding the final

Share Savings Plan Transaction

As a part of the share savings plan for employees in 2024, the following primary insiders have purchased Bakkafrost shares: · Regin Jacobsen, CEO, purchased 49 shares. After the transaction, he holds directly and indirectly 4,641,950 shares. · Høgni Dahl Jakobsen, CFO, purchased 35 shares. After the transaction, he holds directly and indirectly 78,198 shares. · Odd Eliasen, Managing Director, purchased 35 shares. After the transaction, he holds 187,904 shares. · Annika Frederiksberg, Board Member, purchased 13 shares. After the transaction, she holds directly and indirectly 17,

CS MEDICA: Q4 Interim report, July – September 2024

CS MEDICA today released its financial results for the fourth quarter of 2024, demonstrating revenue growth and enhanced operational efficiency despite challenging market conditions and financial constraints. A last-minute postponement of a merger and acquisition initiative impacted the annual results, leading to a 46% deviation from projected revenue.CS MEDICA A/S (CSMED), a Danish MedTech company specializing in CBD-infused medical devices, concluded the fiscal year 2023/2024 with a transformative fourth quarter, marked by progress and positive revenue growth. However, the quarter was

Notice convening the Extraordinary General Meeting of Avida Finans AB (publ), reg. no. 556230-9004 (the "Company")

Day and time: Monday, 30 December 2024, at 10:00 CET. Place: Avida Finans AB (publ)'s office, Magnus Ladulåsgatan 65, 118 28 Stockholm, Sweden.NOTIFICATION ETC. Shareholders who wish to participate in the Extraordinary General Meeting need to i) be listed as a shareholder in the share register maintained by Euroclear Sweden AB no later than on the record date which is Tuesday 17 December 2024, and ii) give notice of participation to the Company no later than on Monday 23 December 2024 in writing to: Avida Finans AB (publ) Box 38101, 100 64 Stockholm, Sweden (mark the envelope "

Notice convening the Extraordinary General Meeting of Avida Finans AB (publ), reg. no. 556230-9004 (the "Company")

Day and time: Monday, 16 December 2024, at 10:00 CET. Place: Avida Finans AB (publ)'s office, Magnus Ladulåsgatan 65, 118 28 Stockholm, Sweden.NOTIFICATION ETC. Shareholders who wish to participate in the Extraordinary General Meeting need to i) be listed as a shareholder in the share register maintained by Euroclear Sweden AB no later than on the record date which is Friday, 6 December 2024, and ii) give notice of participation to the Company no later than on Tuesday, 10 December 2024 in writing to: Avida Finans AB (publ) Box 38101, 100 64 Stockholm, Sweden (mark the envelope "

Lundin Mining Announces Updated Share Capital and Voting Rights

VANCOUVER, BC, November 29, 2024 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) reports the following updated share capital and voting rights, in accordance with the Swedish Financial Instruments Trading Act: The number of issued and outstanding shares of the Company has increased by 28,519 to 776,905,492 common shares with voting rights as of November 29, 2024. The increase in the number of issued and outstanding shares from November 1, 2024 to date is a result of the exercise of employee stock options or the vesting of employee

Lundin Gold Share Capital and Voting Rights Update

VANCOUVER, BC, Nov. 29, 2024 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") reports the following in accordance with the Swedish Financial Instruments Trading Act. As a result of the exercise of stock options under Lundin Gold's equity compensation plan and the exercise of previously granted anti-dilution rights of the Company's largest shareholder during the month of November, the Company now has 240,194,898 common shares issued and outstanding with voting rights as at November 29, 2024.  This figure may be used by

Noble Corporation plc announces changes to its share capital including share repurchases for the month of November 2024

SUGAR LAND, TEXAS, Nov. 29, 2024 /PRNewswire/ - Noble Corporation plc ("Noble") (NYSE: NE, CSE: NOBLE) today announces changes to its share capital. During the month of November, Noble has repurchased approximately USD 36.6 million of A ordinary shares under its previously announced share repurchase plan at a weighted average price of approximately USD 33.85 per A ordinary share. During the period since October 31, 2024, 12,536 new A ordinary shares each with a nominal value of USD 0.00001 have been issued. 6,992 new A ordinary shares have been issued to certain holders of warrants as

There are no items matching the current filter
There are no more items matching the current filter
Back to top